Analyte monitoring device and methods of use

  • US 9,066,694 B2
  • Filed: 04/03/2007
  • Issued: 06/30/2015
  • Est. Priority Date: 04/30/1998
  • Status: Expired due to Fees
  • ×
    • Pin
First Claim
Patent Images

1. A system for providing glucose control, comprising:

  • a glucose sensor configured for transcutaneous positioning such that at least a portion of the sensor is maintained in fluid contact with an interstitial fluid under a skin layer;

    a sensor control unit comprising a radio frequency (rf) transmitter that is configured and arranged to intermittently and repeatedly transmit data related to glucose dependent signals generated by the glucose sensor;

    a display unit comprising an rf receiver to receive the data transmitted by the transmitter, wherein the display unit is configured and arranged to determine a drug administration protocol based on the data and a comparison of a determined glucose value at a predetermined time in the future and a predetermined range, the display unit including an input device for inputting information and an output device for outputting information, wherein the display unit enters a sleep mode if the input device has not been activated for a predetermined period of time, and the sleep mode allows the display unit to receive the data transmitted by the transmitter but not output information associated with the received data on the display unit; and

    a drug administration system which dispenses a drug, the drug administration system comprising a receiver for receiving data from at least one of the sensor control unit or the display unit to direct dispensing of the drug under the control of a processor and in accordance with the determined drug administration protocol;

    wherein the display unit and the drug administration system are integrated in a single housing;

    wherein the display unit is configured to determine a pattern associated with a predetermined physiological condition and to predict an occurrence of a future episode associated with the physiological condition based on the determined pattern; and

    furtherwherein the drug administration system is trainable to modify the drug administration protocol based on the predicted occurrence of the future episode associated with the physiological condition.

View all claims